Delivery Order SPE2DR25D7059-SPE2DR26F7MTL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,463.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on December 3, 2025, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services through AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.06 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, awarded on October 31, 2025, with completion targeted for November 3, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $3,962.03 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,186.58 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This firm fixed price, non-set-aside delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.84 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,411.39 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on August 14, 2025, with a completion date of August 15, 2025. This firm fixed-price delivery order represents a direct purchase of pharmaceutical inventory to support federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.84 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate headquarters location...
- The Defense Logistics Agency awarded a delivery order valued at $8,640.49 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 ml pen injections on September 23, 2025, with completion scheduled for September 24, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical supply needs. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MTLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,845.70 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with completion scheduled for December 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor contract running through December 2026 that supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen provides a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/8/25 |